MFDS — authorised 9 September 1955
- Marketing authorisation holder: UCB INC
- Status: likely_approved
🇰🇷 Xelstrym in South Korea
MFDS authorised Xelstrym on 9 September 1955
Marketing authorisation
Xelstrym in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Nephrology approved in South Korea
Frequently asked questions
Is Xelstrym approved in South Korea?
Yes. MFDS authorised it on 9 September 1955.
Who is the marketing authorisation holder for Xelstrym in South Korea?
UCB INC holds the South Korean marketing authorisation.